Celgene Price Target RAISED and 4 Stock Analyses Buzzing Now

Cabela’s Inc. (NYSE:CAB): Piper Jaffray views Smith & Wesson’s (NASDAQ:SWHC) backlog reported last night as positive for Cabela’s because Cabela’s gains between 15 percent and 20 percent of its sales from firearms. Piper reiterates an Overweight rating but increases its price target for Cabela’s to $55 from $51 after Smith & Wesson’s Q1 results.

Don’t Miss: These 5 Big Banks LOVE Mario Draghi.

Celgene Corporation (NASDAQ:CELG) target has been increased by Cantor following the company report of results from trials of its apremilast for psoriatic arthritis that the firm thinks are positive. The firm keeps a Buy rating on the stock.

Theravance Inc. (NASDAQ:THRX): Piper Jaffray recommends using recent weakness in Theravance shares as a buying opportunity since it thinks that Phase III data for Breo/Relvar and LAMA/LABA support regulatory approval and an eventual takeout by partner GlaxoSmithKline (NYSE:GSK). Piper maintains an Overweight rating and a a $35 price target on the stock.

Mattress Firm Holding Corp (NASDAQ:MFRM): Piper Jaffray notes that  shares of Mattress Firm art down about 10 percent after its Q2 results, the company’s average selling prices saw improvement quarter-to-date and product margin expansion accelerated meaningfully. Piper thinks that Mattress Firm is in the position for very strong earnings growth during 2013, and it keeps an Overweight rating and a $44 price target on the stock.

Abbott Laboratories (NYSE:ABT): RBC Capital believes that there are several upcoming catalysts that it thinks should cause Abbott’s stock to increase by the year’s end. These possible catalysts include AASLD abstracts from AVIATOR, Q3 results which may beat consensus estimates, and a separation into two publicly traded companies by the December’s end. The firm keeps an Outperform rating on the stock.

Don’t Miss: UNVEILED: Amazon’s New Paperwhite and Fire Kindles.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>